Canandaigua National Trust of Florida’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$945K Sell
33,667
-5,224
-13% -$139K 0.76% 26
2025
Q4
$968K Buy
38,891
+276
+0.7% +$6.96K 0.61% 38
2025
Q3
$984K Buy
38,615
+2,298
+6% +$56.7K 0.78% 28
2025
Q2
$880K Buy
36,317
+20,901
+136% +$487K 0.63% 40
2025
Q1
$391K Buy
15,416
+4,874
+46% +$128K 0.34% 74
2024
Q4
$280K Sell
10,542
-26,993
-72% -$732K 0.22% 99
2024
Q3
$1.09M Buy
+37,535
New +$1.09M 0.93% 21

Other funds holding PFE

Canandaigua National Trust of Florida's PFE Position: Q1 2026 in Review

Canandaigua National Trust of Florida reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $139K and leaving 33,667 shares worth $945K. The position accounts for 0.76% of the portfolio, ranked #26.

Canandaigua National Trust of Florida first reported a position in PFE in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.09M in Q3 2024. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Canandaigua National Trust of Florida held 33,667 shares of Pfizer worth $945K as of Q1 2026.
  • Canandaigua National Trust of Florida sold 5,224 Pfizer shares in Q1 2026, an estimated $139K.
  • Pfizer made up 0.76% of Canandaigua National Trust of Florida's portfolio in Q1 2026, its #26 holding.
  • Canandaigua National Trust of Florida first reported a position in Pfizer in Q3 2024 and has held it in 7 quarters since.
  • Canandaigua National Trust of Florida's Pfizer position peaked at $1.09M in Q3 2024.
  • 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Canandaigua National Trust of Florida's 13F filing for Q1 2026, filed 8 Apr 2026.